June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Clinician Judged Visual Impairment and the Clinical Dementia Rating Scale Sum of Boxes in older adults
Author Affiliations & Notes
  • Dandan Diane Zheng
    Psychiatry & Behavioral Sciences, University of Miami School of Medicine, Miami, Florida, United States
  • David Lee
    Public Health Sciences, University of Miami School of Medicine, Miami, Florida, United States
  • Byron L Lam
    Ophthalmology, University of Miami School of Medicine, Miami, Florida, United States
  • Rosie Curiel
    Psychiatry & Behavioral Sciences, University of Miami School of Medicine, Miami, Florida, United States
  • Elizabeth Crocco
    Psychiatry & Behavioral Sciences, University of Miami School of Medicine, Miami, Florida, United States
  • David Loewenstein
    Psychiatry & Behavioral Sciences, University of Miami School of Medicine, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Dandan Zheng None; David Lee None; Byron Lam None; Rosie Curiel None; Elizabeth Crocco None; David Loewenstein None
  • Footnotes
    Support  K01AG080120
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 4218. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Dandan Diane Zheng, David Lee, Byron L Lam, Rosie Curiel, Elizabeth Crocco, David Loewenstein; Clinician Judged Visual Impairment and the Clinical Dementia Rating Scale Sum of Boxes in older adults. Invest. Ophthalmol. Vis. Sci. 2023;64(8):4218.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Visual impairment has been demonstrated to be associated with cognitive decline in older adults. However, the relationship between visual impairment and the severity of dementia is poorly understood.

Methods : 10,146 Participants aged 65 years and older from the National Alzheimer's Coordinating Center’s uniform data with baseline in-person visits from 2015 to 2021 were included. The mean age was 73.8 (SD 6.2) years (57% female, 14.0% Black, 9.3% Hispanic). Severity of dementia was measured by the Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) (mean score 1.9, SD 3.2, range 0-18, data skewed). Of the participants, 44.6% were cognitively normal (mean CDR-SOB 0.12), 30.5% had mild cognitive impairment (mean CDR-SOB 1.28), and 24.9% had dementia (mean CDR-SOB 5.95). During the visit, clinician judged visual function with and without corrective eyewear. Vision status was categorized into normal vision (92.3%), impaired vision (4.7%), and unknown vision (2.9%). Analysis of variance and negative binomial regression with CDR-SOB as outcome and vision status as predictor of interest were conducted to estimate the associations.

Results : In subjects with dementia, those with impaired vision and those with unknown vision had higher CDR-SOB scores compared to normal vision (mean 5.67, 6.67 and 8.32 for normal vision, impaired vision, and unknown vision respectively, P<0.01). In a negative binomial regression of the entire sample, after adjusting for age, gender, race, Hispanic ethnicity, education, cognitive function, number of APOE e4 alleles, and the number of medications, impaired vision and unknown vision were associated with higher CDR-SOB scores compared to normal vision (Incidence rate ratio (IRR) 1.26, 95% CI [1.11, 1.44], p < 0.001 for impaired vision, and IRR 1.27, 95% CI [1.06, 1.53], P=0.01 for unknown vision) indicating worse dementia severity.

Conclusions : In this large US multicenter Alzheimer’s Disease research center population, clinician judged visual impairment was associated with greater CDR-SOB adjusting for numerous covariates. Increased CDR-SOB scores are indicative of greater cognitive and functional impairment and more severe dementia staging. Persons with impaired vision or unknown vision are more likely to have advanced dementia staging. Clinician awareness of this association may be helpful for patient care.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×